Ami E. Simunovich serves as executive vice president and chief regulatory officer for BD (Becton, Dickinson and Company), a leading global medical technology company headquartered in Franklin Lakes, New Jersey. She is also a member of the BD Executive Leadership Team.
Prior to her current role, Simunovich served as chief regulatory counsel, advising in the management of complex global regulatory law and international regulatory legal matters.
Simunovich previously served as associate general counsel of regulatory and compliance, at C. R. Bard, Inc., a leading medical technology company in the fields of vascular, urology and surgical specialty products, which BD acquired in 2017. Prior to Bard, Simunovich was associate general counsel of regulatory at Catalent, Inc., a Blackstone Portfolio Company and global contract manufacturer of pharmaceuticals, biologics and dietary supplements. She also has served as legal counsel in litigation, regulatory law and intellectual property at a New York-based law firm.
Simunovich earned her doctorate in pharmacy from the Ernest Mario School of Pharmacy at Rutgers University and a doctorate in law from Seton Hall University School of Law.